seekingalpha.com
/1 month ago
Latest updates for Gild
Fresh curated links around GILD are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Gilead Sciences, Inc. (GILD) Q2 2026 Earnings Call Transcript
- Rosen Law Firm Encourages Gildan Activewear Inc. Investors to Inquire About Securities Class Action Investigation - GIL
- Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Pl
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
qchron.com
/3 weeks ago
Rosen Law Firm Encourages Gildan Activewear Inc. Investors to Inquire About Securities Class Action Investigation - GIL
NEW YORK, Aug. 13, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Gildan...
fool.com
/4 days ago
Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Pl...
Gilead Sciences is branching out beyond its HIV franchise into oncology and immunology therapies.
finance.yahoo.com
/2 weeks ago
Gilead’s HIV Business is Surging, but is the Company Too Dependent on One Franchise?
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Gild
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
fool.com
Recent coverage from public sources
Public source
qchron.com
Recent coverage from public sources
Public source